COPENHAGEN, Denmark, Jan. 10, 2025 /PRNewswire/ -- Cmbio(R) , a global leader in multi-omics science and digital biology, is pleased to announce the purchase of the e[datascientist](TM) software ...

A new artificial intelligence-powered tool called MISO (Multi-modal Spatial Omics) can detect cell-level characteristics of cancer by looking at data from extremely small pieces of tissue-some as ...

Multifactorial diseases pose a significant global health challenge, impacting economically developed nations with conditions ...

Cancer doesn’t follow a linear path—it evolves, adapts, and forks. Even within a single tumor, individual cells behave differently. They mutate, diverge, and form heterogeneous clones that fuel ...

Artificial Intelligence–Powered Human Epidermal Growth Factor Receptor 2 Quantification and Clinical Outcomes in Human Epidermal Growth Factor Receptor 2–Positive Biliary Tract Cancer Treated With ...

The integration of multi-omics approaches in drug discovery is rapidly gaining momentum, offering a more comprehensive understanding of disease biology and paving the way for personalized medicine. A ...

Enhanc3D Genomics (‘Enhanced’), an innovator in 3D genomics technology, today announced the launch of a suite of integrated multi-omics solutions to accelerate and improve the precision of drug ...

We analyzed bulk transcriptome sequencing data from 10 cohorts of sepsis patients. Using unbiased patient clustering, we identified three subtypes with significantly different prognoses, which were ...

We resent it when preliminary or ancillary work occupies so much of our attention that our real work, or what we consider to be our real work, recedes. No less a figure than Enrico Fermi, when ...

We compared the TuPro melanoma cohort (n = 98), which received multi-omics–guided selection of adjuvant, standard of care and beyond standard-of-care therapies in patients with advanced melanoma, to a ...